XML 54 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Considerations (Tables)
12 Months Ended
Jun. 30, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Schedule of fair value on a recurring basis

    

Fair Value Measurements at June 30, 2021

Quoted

Priced in

Active

Markets

Significant

for

Other

Significant

Identical

Observable

Unobservable

    

Fair Value at June 30, 

    

Assets

    

Inputs

    

Inputs

2021

 

(Level 1)

 

(Level 2)

 

(Level 3)

(In thousands)

Recurring:

 

 

Contingent consideration

 

$

12,057

 

$

 

$

 

$

12,057

CVR liability

 

1,395

 

 

 

1,395

Total

$

13,452

 

$

 

$

$

13,452

    

Fair Value Measurements at June 30, 2020

Quoted

Priced in

Active

Markets

Significant

for

Other

Significant

Identical

Observable

Unobservable

    

Fair Value at June 30, 

    

Assets

    

Inputs

    

Inputs

2020

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

(In thousands)

Recurring:

Contingent consideration

$

13,588

 

$

 

$

 

$

13,588

CVR liability

5,572

 

 

 

5,572

Total

$

19,160

 

$

 

$

$

19,160

Schedule of fair value on a nonrecurring basis

    

Fair Value Measurements at June 30, 2021

Quoted

Priced in

Active

Markets

Significant

for

Other

Significant

Identical

Observable

Unobservable

Fair Value at June 30, 

Assets

Inputs

Inputs

2021

(Level 1)

(Level 2)

(Level 3)

(In thousands)

Non-recurring

 

  

 

  

 

  

 

  

Fixed payment arrangements

$

9,458

$

$

$

9,458

$

9,458

$

$

$

9,458

    

Fair Value Measurements at June 30, 2020

Quoted

Priced in

Active

Markets

Significant

for

Other

Significant

Identical

Observable

Unobservable

    

Fair Value at June 30, 

    

Assets

    

Inputs

    

Inputs

2020

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

(In thousands)

Non-recurring

Fixed payment arrangements

$

13,512

 

$

 

$

 

$

13,512

Total

$

13,512

 

$

 

$

$

13,512

Schedule of changes in Level 3 inputs

    

CVR

    

Contingent

Fixed Payment

Liability

Consideration

Arrangements

(In thousands)

Balance as of June 30, 2019

 

$

$

23,326

$

Included in earnings

 

 

523

 

(9,741)

 

1,452

Purchases, issues, sales and settlements:

 

 

  

 

  

 

  

Purchases

 

 

7,049

 

183

 

Issues

29,838

Settlements

 

 

(2,000)

 

(180)

 

(17,778)

Balance as of June 30, 2020

5,572

13,588

13,512

Included in earnings

 

(3,177)

(848)

2,795

Purchases, issues, sales and settlements:

 

 

Settlements

 

 

(1,000)

 

(683)

 

(6,849)

Balance as of June 30, 2021

 

$

1,395

$

12,057

$

9,458

Contingent Value Rights  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Schedule of significant assumptions used in valuation

June 30, 

    

2021

    

2020

Contingent Value Rights

 

  

 

  

Valuation method

Monte Carlo

Monte Carlo

Leveraged Beta

 

0.91

 

0.88

Market risk premium

6.00

%

6.17

%

Risk-free interest rate

0.36

%

1.15

%

Discount

13.00

%

30.00

%

Company specific discount

 

5.00

%

 

20.00

%

Fixed Payment Arrangements  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Schedule of significant assumptions used in valuation

    

June 30, 

2021

2020

Fixed Payment Obligations

 

  

 

  

Valuation method

Discounted Cash Flow

Discounted Cash Flow

Discount rate - minimum

10.0

%

1.8

%

Discount rate - maximum

 

12.4

%

 

12.4

%

Tuzistra XR | Contingent Consideration  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Schedule of significant assumptions used in valuation

    

June 30, 

2021

2020

Tuzistra

 

  

 

  

Valuation model

Scenario-Based

Discounted Cash Flow

Leveraged Beta

 

0.68

 

0.36

Market risk premium

 

6.00

%  

6.00

%

Risk-free interest rate

 

1.90

%  

3.00

%

Discount

 

15.30

%  

5.20

%

Company specific discount

 

15.00

%  

15.00

%

ZolpiMist | Contingent Consideration  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Schedule of significant assumptions used in valuation

    

June 30, 

2021

2020

ZolpiMist

 

  

 

  

Valuation method

Monte Carlo

Discounted Cash Flow

Leveraged Beta

 

1.09

 

1.17

Market risk premium

 

6.00

%  

6.00

%

Risk-free interest rate

 

0.70

%  

3.00

%

Discount

 

10.30

%  

5.20

%

Company specific discount

 

15.00

%  

5.00

%